Drug Type Small molecule drug |
Synonyms Mixture of Polyenephosphatidylcholine (For oral preparation), Polyene Phosphatidylcholine, Polyenephosphatidyl choline (JAN) + [4] |
Target- |
Action modulators |
Mechanism Immunomodulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (18 Nov 2005), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Chronic liver disease | Japan | 31 Aug 2007 | |
Hyperlipidemias | Japan | 31 Aug 2007 | |
Fatty Liver | China | 18 Nov 2005 | |
Hepatitis | China | 18 Nov 2005 | |
Hepatitis A | China | 18 Nov 2005 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Localized obesity | Phase 2 | United States | 01 Jul 2019 | |
Obesity | Phase 1 | South Korea | 30 Jan 2022 | |
Fractures, Bone | Preclinical | China | 30 Jul 2024 |
Phase 1 | 26 | AYP-101 250 mg | pyclisbxpj(eyrfyvwcfi) = oumzisturm ylsryassis (oefcuwkgap ) View more | Positive | 28 Dec 2024 | ||
AYP-101 500 mg | pyclisbxpj(eyrfyvwcfi) = csiwvzzhuv ylsryassis (oefcuwkgap ) View more |